Features Partner Sites Information LinkXpress
Sign In
Demo Company

New Line of Small Benchtop Centrifuges Minimizes Space Requirement While Maximizing Flexibility

By BiotechDaily International staff writers
Posted on 06 Jun 2013
Print article
 Image: The new Thermo Scientific SL 8 small benchtop centrifuge (Photo courtesy of Thermo Fisher Scientific).
Image: The new Thermo Scientific SL 8 small benchtop centrifuge (Photo courtesy of Thermo Fisher Scientific).
A new line of benchtop centrifuges was designed to provide exceptional capacity in a compact design with a smart, simple interface and the flexibility to support both clinical and research applications.

Sale of the new instrument was recently launched by Thermo Fisher Scientific Inc. (Milford, MA, USA). The new line of centrifuges is highlighted by a particularly compact footprint, which conserves valuable laboratory bench space. Nonetheless, the instrument can accommodate eight 50 mL tubes, four microplates, or 30 filtration columns in a swinging bucket rotor. The "Auto-Lock" rotor exchange enables rotor replacement in less than three seconds while delivering trouble-free rotor installation and removal and clear chamber access for cleaning convenience.

The centrifuges are manufactured with quality materials providing broad chemical resistance with exceptional strength for durability and reliability. The instrument is controlled via an intuitive glove and detergent friendly interface with a bright backlit display, featuring one-touch operation with preset protocol options and optional password protection.

“Centrifuges are critical laboratory resources that are in constant use and demand. It is crucial to avoid bottlenecks in these lab workflows that could create unwanted downtime and negatively impact users’ work,” said Maurizio Merli, product director at Thermo Fisher Scientific. “With features designed to optimize simplicity, safety, and flexibility, the new Thermo Scientific small benchtop centrifuges can help scientists save time and maximize resources in busy labs and clinics.”

Related Links:
Thermo Fisher Scientific Inc.

Print article



view channel
Image: Glioblastoma multiforme (GBM) (Photo courtesy of the University of California, San Diego School of Medicine).

How Blocking TROY Signaling Slows Brain Cancer Growth

Cancer researchers have found how the low molecular weight drug propentofylline (PPF) slows the growth of the aggressive brain tumor glioblastoma multiforme (GBM). This form of brain cancer is the most... Read more


view channel

Molecular Light Shed on “Dark” Cellular Receptors

Scientists have created a new research tool to help find homes for orphan cell-surface receptors, toward better understanding of cell signaling, developing new therapeutics, and determining causes of drug side-effects. The approach may be broadly useful for discovering interactions of orphan receptors with endogenous, naturally... Read more


view channel

Purchase of Biopharmaceutical Company Will Boost Development of Nitroxyl-Based Cardiovascular Disease Drugs

A major international biopharmaceutical company has announced the acquisition of a private biotech company that specializes in the development of drugs for treatment of cardiovascular disease. Bristol-Myers Squibb Co. (New York, NY, USA) has initiated the process to buy Cardioxyl Pharmaceuticals Inc. (Chapel Hill, NC, USA).... Read more
Copyright © 2000-2015 Globetech Media. All rights reserved.